Mimedx (MDXG) Consolidated Net Income (2011 - 2026)

Mimedx has disclosed Consolidated Net Income across 16 years of filings, most recently posting -$14.8 million for Q2 2026.

• In Q2 2026, Consolidated Net Income fell 254.29% year-over-year to -$14.8 million; the TTM figure through Jun 2026 stood at $6.2 million (down 80.61% YoY), while the FY2025 annual figure was $48.6 million, up 14.52% from the prior year.
• Consolidated Net Income came in at -$14.8 million for Q2 2026 at Mimedx, down from -$10.9 million in the prior quarter.
• In the past five years, Consolidated Net Income ranged from a high of $53.5 million in Q4 2023 to a low of -$14.8 million in Q2 2026.
• Average Consolidated Net Income over 5 years is $5.8 million, with a median of $7.8 million recorded in 2024.
• The largest YoY upside for Consolidated Net Income was 4839.7% in 2022 against a maximum downside of 510.91% in 2022.
• Over 5 years, Consolidated Net Income stood at $9.8 million in 2022, then soared by 444.02% to $53.5 million in 2023, then sank by 86.09% to $7.4 million in 2024, then surged by 104.24% to $15.2 million in 2025, then tumbled by 197.69% to -$14.8 million in 2026.
• Per Business Quant data, the three most recent Consolidated Net Income figures were -$14.8 million in Q2 2026, -$10.9 million in Q1 2026, and $15.2 million in Q4 2025.